A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: Radiation therapy oncology group trial 0418

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 1, 2012, Pages

  Jhingran, Anuja ^a   Winter, Kathryn ^b   Portelance, Lorraine ^c   Miller, Brigitte ^d   Salehpour, Mohammad ^a   Gaur, Rakesh ^e   Souhami, Luis ^f   Small Jr , William ^g   Berk, Lawrence ^h   Gaffney, David ⁱ  

^a UNIVERSITY OF TEXAS   (United States)

^b RTOG Statistical Center   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d CAROLINAS MEDICAL CENTER   (United States)

^e ST LUKE S HOSPITAL   (United States)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^g NORTHWESTERN UNIVERSITY   (United States)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENTS; DOSE PRESCRIPTION; DOSE-VOLUME; ENDOMETRIAL CANCER; ENDOMETRIAL CARCINOMAS; FEMORAL HEADS; INTENSITY-MODULATED RADIATION THERAPY; NODAL TISSUE; NORMAL STRUCTURE; ORGANS AT RISKS; PHASE II; PLANNING TARGET VOLUMES; RADIATION THERAPY ONCOLOGY GROUPS;

DISEASES; QUALITY ASSURANCE; RADIOTHERAPY; SOCIETIES AND INSTITUTIONS;

PHYSICAL THERAPY;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; BLADDER; CANCER STAGING; DIARRHEA; ENDOMETRIUM CARCINOMA; ENTERITIS; ENTEROPATHY; FEMUR HEAD; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTESTINE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROCTITIS; QUALITY CONTROL; RADICAL HYSTERECTOMY; RECTUM; SALPINGOOOPHORECTOMY; VAGINAL HYSTERECTOMY;

ADULT; AGED; ENDOMETRIAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FEMUR HEAD; HUMANS; INTESTINES; MIDDLE AGED; ORGANS AT RISK; POSTOPERATIVE CARE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; URINARY BLADDER; VAGINA;

EID: 84865691285     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.02.044     Document Type: Article

References (19)

1. H.M. Keys, J.A. Roberts, and V.L. Brunetto A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 2004 744 751
2. A.N. Scholten, W.L. Van Putten, and H. Beerman Postoperative radiotherapy for Stage I endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review Int J Radiat Oncol Biol Phys 63 2005 834 838
3. M.J. Gallagher, H.D. Brereton, and R.A. Rostock A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation Int J Radiat Oncol Biol Phys 12 1986 1565 1573
4. B.W. Corn, R.M. Lanciano, and K.M. Greven Impact of improved irradiation technique, age and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis J Clin Oncol 12 1994 510 515
5. J.C. Roeske, A. Lujan, and J. Rotmensch Intensity-modulated whole pelvic radiation in patients with gynecologic malignancies Int J Radiat Oncol Biol Phys 48 2000 1613 1621
6. A. Ahamad, W. D'Souza, and M. Salehpour Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size Int J Radiat Oncol Biol Phys 62 2005 1117 1124
7. A.J. Mundt, A.E. Lujan, and J. Romensch Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies Int J Radiat Oncol Biol Phys 52 2002 1330 1337
8. A.J. Mundt, L.K. Mell, and J.C. Roeske Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy Int J Radiat Oncol Biol Phys 56 2003 1354 1360
9. International Commission on Radiation Units and Measurements Prescribing, recording and reporting photon beam therapy. Report 62 1999 ICRU Bethesda, MD
10. J.R. Palta, J.A. Deye, and G.S. Ibbott Credentialing of institutions for IMRT Int J Radiat Oncol Biol Phys 59 2004 1257 1262
11. R. Simon Optimal two-stage designs for phase II clinical trials Control Clin Trials 10 1989 1 10
12. W.A.I. Peters, P.Y. Liu, and R. Barrett Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy. Report of a phase III Intergroup Study Gynecol Oncol 72 1999 443
13. J.C. Roeske, D. Bonta, and L.K. Mell A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy Radiother Oncol 69 2003 201 207
14. E.Y. Huang, C.C. Sung, and S.F. Ko The different volume effects of small-bowel toxicity during pelvic irradiation between gynecological patients with and without abdominal surgery: a prospective study with computed-tomography-based dosimetry Int J Radiat Oncol Biol Phys 69 2007 732 739
15. L.M. Tho, M. Glegg, and J. Paterson Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer; investigating dose-volume relationships and role for inverse planning Int J Radiat Oncol Biol Phys 66 2006 505 513
16. J.M. Robertson, D. Lockman, and D. Yan The dose-volume relationships of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer Int J Radiat Oncol Biol Phys 70 2008 413 418
17. C. Fiorine, R. Valdagni, and T. Rancati Dose-volume effects for normal tissues in external radiotherapy: pelvis Radiother Oncol 93 2009 153 167
18. A. Jhingran, M. Salehpour, and M. Sam Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy [e-pub ahead of print] Int J Radiat Oncol Biol Phys 82 2012 256 262
19. G. Sanguineti, M. Little, and J.E. Endres Comparison of three strategies to delineate the bowel for whole pelvis IMRT of prostrate cancer Radiother Oncol 88 2008 95 101